# Understanding immunosuppression medication adherence in kidney transplant recipients: a cross-sectional exploration of the role of illness perceptions, medication beliefs and perceived behavioural control

**Authors:** Rosie Heape, Antonia J. Cronin, Lyndsay Hughes

PMC · DOI: 10.1080/21642850.2025.2562857 · Health Psychology and Behavioral Medicine · 2025-10-14

## TL;DR

This study explores why kidney transplant recipients don't take their immunosuppression medication as prescribed, focusing on their perceptions and beliefs.

## Contribution

The study identifies perceived behavioral control and illness perceptions as key factors in medication non-adherence among kidney transplant recipients.

## Key findings

- Over half of participants reported some form of non-adherence to immunosuppression medication.
- Unintentional non-adherence was more common than intentional non-adherence.
- Combining illness perceptions and perceived behavioral control explained significant variance in non-adherence types.

## Abstract

Non-adherence to immunosuppression medication (ISM) is common in kidney transplant recipients (KTRs), despite being associated with poor clinical outcomes. Understanding potentially modifiable contributors to non-adherence is essential for developing effective interventions. This study explored the relationship between components of the Common-Sense Model (CSM), including illness perceptions (graft-specific and of kidney disease more broadly) and beliefs about ISM, as well as perceived behavioural control (PBC), and total, intentional and unintentional ISM non-adherence in KTRs.

A cross-sectional observational study was conducted with N = 296 KTRs. Participants completed self-report measures including the Brief Illness Perception Questionnaire, Beliefs about Medicines Questionnaire, questions assessing PBC, and the Medication Adherence Report Scale. Hierarchical binary logistic regression analyses were conducted to examine the explanatory value of variables on adherence outcomes.

Over half of participants (57%) reported any indication of non-adherence. Unintentional non-adherence was reported more frequently (54%) than intentional non-adherence (14%). Combining CSM components with PBC best explained variance in total (Nagelkerke R2 = 19.8%), intentional (Nagelkerke R2 = 15.5%), and unintentional non-adherence (Nagelkerke R2 = 19.3%).

Enhancing PBC around taking ISM may offer a valuable intervention target, particularly when addressed alongside CSM components to reduce both intentional and unintentional non-adherence.

## Linked entities

- **Diseases:** kidney disease (MONDO:0001343)

## Full-text entities

- **Diseases:** kidney disease (MESH:D007674)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12529741/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12529741/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12529741/full.md

---
Source: https://tomesphere.com/paper/PMC12529741